Literature DB >> 29473107

Reply to: "All that glitters is not gold - new reconstruction methods using Deauville criteria for patient reporting".

Charline Lasnon1,2, Blandine Enilorac3, Nicolas Aide4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29473107     DOI： 10.1007/s00259-018-3938-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  13 in total

1.  SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma.

Authors:  René-Olivier Casasnovas; Michel Meignan; Alina Berriolo-Riedinger; Stéphane Bardet; Anne Julian; Catherine Thieblemont; Pierre Vera; Serge Bologna; Josette Brière; Jean-Philippe Jais; Corinne Haioun; Bertrand Coiffier; Franck Morschhauser
Journal:  Blood       Date:  2011-04-25       Impact factor: 22.113

2.  All that glitters is not gold - new reconstruction methods using Deauville criteria for patient reporting.

Authors:  Sally F Barrington; Tom Sulkin; Adam Forbes; Peter W M Johnson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-02       Impact factor: 9.236

3.  Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

Authors:  Heiko Schöder; Ariela Noy; Mithat Gönen; Lijun Weng; David Green; Yusuf E Erdi; Steven M Larson; Henry W D Yeung
Journal:  J Clin Oncol       Date:  2005-04-18       Impact factor: 44.544

4.  Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma.

Authors:  Anne-Ségolène Cottereau; Sebastien Hapdey; Loic Chartier; Romain Modzelewski; Olivier Casasnovas; Emmanuel Itti; Herve Tilly; Pierre Vera; Michel A Meignan; Stéphanie Becker
Journal:  J Nucl Med       Date:  2016-10-06       Impact factor: 10.057

5.  Does PET Reconstruction Method Affect Deauville Score in Lymphoma Patients?

Authors:  Blandine Enilorac; Charline Lasnon; Cathy Nganoa; Christophe Fruchart; Anne-Claire Gac; Gandhi Damaj; Nicolas Aide
Journal:  J Nucl Med       Date:  2017-12-14       Impact factor: 10.057

6.  FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

Authors:  Ronald Boellaard; Roberto Delgado-Bolton; Wim J G Oyen; Francesco Giammarile; Klaus Tatsch; Wolfgang Eschner; Fred J Verzijlbergen; Sally F Barrington; Lucy C Pike; Wolfgang A Weber; Sigrid Stroobants; Dominique Delbeke; Kevin J Donohoe; Scott Holbrook; Michael M Graham; Giorgio Testanera; Otto S Hoekstra; Josee Zijlstra; Eric Visser; Corneline J Hoekstra; Jan Pruim; Antoon Willemsen; Bertjan Arends; Jörg Kotzerke; Andreas Bockisch; Thomas Beyer; Arturo Chiti; Bernd J Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-12-02       Impact factor: 9.236

Review 7.  EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies.

Authors:  Nicolas Aide; Charline Lasnon; Patrick Veit-Haibach; Terez Sera; Bernhard Sattler; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-16       Impact factor: 9.236

8.  Impact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs).

Authors:  Charline Lasnon; Blandine Enilorac; Hosni Popotte; Nicolas Aide
Journal:  EJNMMI Res       Date:  2017-03-31       Impact factor: 3.138

9.  PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study.

Authors:  Sally F Barrington; Amy A Kirkwood; Antonella Franceschetto; Michael J Fulham; Thomas H Roberts; Helén Almquist; Eva Brun; Karin Hjorthaug; Zaid N Viney; Lucy C Pike; Massimo Federico; Stefano Luminari; John Radford; Judith Trotman; Alexander Fosså; Leanne Berkahn; Daniel Molin; Francesco D'Amore; Donald A Sinclair; Paul Smith; Michael J O'Doherty; Lindsey Stevens; Peter W Johnson
Journal:  Blood       Date:  2016-01-08       Impact factor: 22.113

10.  EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems.

Authors:  Andres Kaalep; Terez Sera; Wim Oyen; Bernd J Krause; Arturo Chiti; Yan Liu; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-01       Impact factor: 9.236
View more
  4 in total

1.  Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis.

Authors:  Nicolas Aide; Thibault Salomon; Charline Lasnon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-07-14       Impact factor: 9.236

2.  Comparison of different automatic methods for the delineation of the total metabolic tumor volume in I-II stage Hodgkin Lymphoma.

Authors:  Queralt Martín-Saladich; Gabriel Reynés-Llompart; Aida Sabaté-Llobera; Azahara Palomar-Muñoz; Eva Domingo-Domènech; Montse Cortés-Romera
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.379

3.  New PET technologies - embracing progress and pushing the limits.

Authors:  Nicolas Aide; Charline Lasnon; Adam Kesner; Craig S Levin; Irene Buvat; Andrei Iagaru; Ken Hermann; Ramsey D Badawi; Simon R Cherry; Kevin M Bradley; Daniel R McGowan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-03       Impact factor: 9.236

4.  Positron emission tomography PET/CT harmonisation study of different clinical PET/CT scanners using commercially available software.

Authors:  Gerry Lowe; Bruce Spottiswoode; Jerome Declerck; Keith Sullivan; Mhd Saeed Sharif; Wai-Lup Wong; Bal Sanghera
Journal:  BJR Open       Date:  2020-06-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.